Twist Bioscience Corporation TWST APAC — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's apac — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's APAC — revenue?
- Twist Bioscience Corporation (TWST) reported APAC — revenue of $9.06M in Q1 2026.
- How has Twist Bioscience Corporation's APAC — revenue changed year-over-year?
- Twist Bioscience Corporation's APAC — revenue increased by 30.1% year-over-year, from $6.96M to $9.06M.
- What is the long-term trend for Twist Bioscience Corporation's APAC — revenue?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's APAC — revenue has grown at a 26.9% compound annual growth rate (CAGR), from $10.3M to $26.75M.
- What does APAC — revenue mean?
- This metric represents the total gross revenue generated from sales and services within the Asia-Pacific geographic region. It reflects the company's market penetration and commercial success in capturing demand for synthetic biology products and DNA synthesis solutions in this specific territory. Tracking this figure helps investors assess the geographic diversification of the company's revenue streams and the scalability of its international operations.